Clinical Trials Logo

Clinical Trial Summary

To document indications for cholangioscopy and clinical utility of the SpyGlass Direct Visualization System in China when used per standard of practice.

Prospective, Post market, Multi-center, Non-randomized Study


Clinical Trial Description

Patients who presenting with an indication for cholangioscopy or presenting with a possible indication for cholangioscopy to be determined during the ERCP procedure immediately preceding the SpyGlass procedure will join this study, totally 500 patients across 16 sites throughout China will participate in study. After SpyGlass operation, all patients will be followed for 72 hours to observe adverse events, and patients with indeterminate stricture or undefined filling defect indication with tissue sampling not yielding histopathology positive for malignancy and unresolved device and/or procedure related SAE at 72 Hours will continue to be followed up until 6 months. Finally, procedure success rate will be analyzed as primary endpoint, and SAEs and impact of patients management will be analyzed as secondary endpoint. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02287194
Study type Observational [Patient Registry]
Source Boston Scientific Corporation
Contact
Status Completed
Phase
Start date November 28, 2014
Completion date December 31, 2017

See also
  Status Clinical Trial Phase
Completed NCT02971579 - A Register on the Quality of ERCP and Training of Endoscopists in Italy
Recruiting NCT02310230 - An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy N/A
Not yet recruiting NCT01900938 - Comparison Between Continuous Infusion and Intermittent Bolus Injection of Propofol for Deep Sedation During ERCP N/A
Completed NCT00370344 - Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease Phase 2/Phase 3
Suspended NCT04559867 - Fistulotomy as the Primary Cannulation Technique for All Patients Undergoing ERCP: A Randomized, Controlled Trial N/A
Enrolling by invitation NCT04572711 - Prospective Evaluation of Biliary Tissue Sampling With ERCP
Recruiting NCT01715220 - Treatment of Suspected Cholelithiasis With Nitroglycerin Phase 2
Not yet recruiting NCT06015074 - Ciprofol vs Propofol for Reducing Hypoxia Incidence in ERCP N/A
Recruiting NCT05249400 - Effect of Off-site Assistance on Success Rate of Selective Cannulation During hands-on ERCP Training N/A
Active, not recruiting NCT03190343 - Assessment of Cholangio-pancreatoscopy for the Diagnosis and the Treatment of Biliary and Pancreatic Diseases
Withdrawn NCT00672698 - Evaluation of Surgical Risk in Elderly Patients Submitted to Elective Surgery N/A
Completed NCT00751998 - Spy II Clinical Registry
Completed NCT04604652 - Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis Phase 2
Completed NCT02353286 - Endoscopic Treatment of Benign Biliary Strictures and Cystic Duct Leakages With a Novel Biodegradable Biliary Stent N/A
Recruiting NCT03074708 - Application of 3D Visualization and 3D Printing in the Hepatobiliary and Pancreatic Surgery N/A
Not yet recruiting NCT06276153 - Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer
Withdrawn NCT03678480 - A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC) Phase 2
Completed NCT04115696 - Biodegradable Stent Implantation in Biliary Benign Strictures.
Recruiting NCT04391426 - Analysis of Biliary Microbiota in Hepatobiliopancreatic Diseases Compared to Healthy People [MICROBILIO]
Completed NCT01350037 - Alfentanil Versus Remifentanil in Patient-controlled Sedation During Endoscopic Retrograde Cholangiopancreatography (ERCP) Phase 4